IBB — iShares Biotechnology ETF price, holdings and performance

iShares Biotechnology ETF

iShares Biotechnology ETF (NASDAQ: IBB) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
204.56
-2.51-1.21%
OverviewShort InterestFilings
IBBiShares Biotechnology ETF·NASDAQ
204.56-1.21%
TA
Loading chart...
Screen all →
VXUS-0.72%$85.88VUG+0.36%$88.75VTV-0.24%$221.25VO-0.19%$80.00VB-0.45%$289.61VWO+0.17%$60.01VGT+0.68%$122.31VIG-0.05%$237.00
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y42.70%Total Holdings244Perf Week0.80%
SponsorISharesETF TypeTagssectorReturn% 3Y17.37%AUM$10.30BPerf Month-5.72%
Fund FamilyBond TypeTags-Return% 5Y4.01%NAV/shPerf Quarter17.81%
Index-Average MaturityTags-Return% 10Y52W High217.11 -5.78%Perf Half Y24.38%
Index WeightingCommodity TypeTags-Return% SI52W Low138.79 47.39%Perf YTD21.21%
Active/PassiveQuant TypeTags-Flows% 1M0.00%Volatility1.56% 1.59%Perf Year45.08%
Dividend TTM0.34 (0.17%)ESG TypeTags-Flows% 3M6.08%ATR (14)3.88Perf 3Y60.94%
Dividend Ex-DateSep 15, 2026Dividend TypeSector/ThemeFlows% YTD13.69%RSI (14)49.52Perf 5Y18.09%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.69Perf 10Y113.06%
Expense0.44%Growth/ValueSMA20-2.12%Flows% 3YRel Volume0.84Prev Close207.07
Inverse/LeveragedMarket CapSMA502.36%Flows% 5YAvg Volume1.62MPrice204.56
IPO DateFeb 04, 2001Option/ShortYes / YesSMA20014.20%52W Range %84%Volume1,355,052Change-1.21%
Assets Under Management
03.00B6.00B9.00B12.00BFebMayJulSepNov'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Sep-18-26
Sep-18-2605:30AM
HQH: Over 10% Yield On This Healthcare FundSeekingAlpha
Sep-16-26
Sep-16-2612:12AM
iShares Biotechnology ETF $IBB Shares Acquired by NewEdge Advisors LLCdefenseworld.net
Sep-08-26
Sep-08-2609:13AM
S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market TodayBenzinga
Sep-07-26
Sep-07-2608:22AM
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?247wallst.com
Sep-01-26
Sep-01-2608:51AM
Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market TodayBenzinga
08:25AM
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFsbenzinga.com
Aug-31-26
Aug-31-2603:21AM
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?zacks.com
Aug-25-26
Aug-25-2609:00AM
Bitcoin Tops $80,000, Oil Sinks As Navy Clears Hormuz Mines: Stock Market TodayBenzinga
Aug-21-26
Aug-21-2606:06AM
Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session247wallst.com
Aug-20-26
Aug-20-2608:03AM
Biotech Is Booming, But These 2 Stocks Missed the Memobenzinga.com
Aug-19-26
Aug-19-2601:49PM
Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting ForBenzinga
Aug-16-26
Aug-16-2606:54PM
Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yesseekingalpha.com
Aug-13-26
Aug-13-2603:06AM
‘Never Happened in History,' Ex-Bridgewater Exec Warns AI Market Is Priced to Perfectionbenzinga.com
Aug-11-26
Aug-11-2608:30PM
Nearly A Third Of Tech Has Raised GuidanceSeekingAlpha
Aug-06-26
Aug-06-2609:15PM
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocksbarrons.com
Fund

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR